TRUSYNERGY

Lobbying for BURRELL INTERNATIONAL GROUP LLC (ON BEHALF OF SHIONOGI INC.) · Government relations & lobbying

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $10,000.00 income · posted Jan 9, 2026

Lobbying activity 1

Pharmacy

Funding for the SNS, BARDA, and IBMSC; promoting safer and more effective treatments in the stockpile; promoting onshoring and domestic manufacturing of medicines and their components; prioritizing investments in more effective treatments to combat AMR; PASTEUR Act; reauthorization of the Pandemic and All Hazards Preparedness Act; funding and incentives for MCM development; AMR issues; development of infectious disease and AMR treatments; FY 26 LHHS appropriations; Rare Pediatric Disease Priority Review Voucher; MFN drug pricing; tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.